Fluorouracil Accord Healthcare 50 mg/ml oplossing voor injectie of infusie
Sponsors
Hopital Erasme, Groupe Belge D'Oncologie Digestive
Conditions
METASTATIC PANCREATIC DUCTAL ADENOCARCINOMAPancreatic adenocarcinomasmall bowel adenocarcinoma
Phase 2
Preoperative treatment with mFOLFIRINOX (or Gem-Nab-P) +/- isotoxic high-dose Stereotactic Body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma:
a randomised comparative multicentre phase II study (STEREOPAC)
RecruitingCTIS2022-501181-22-01
Start: 2023-02-06Target: 256Updated: 2024-01-10
“NALPAC” A NON-COMPARATIVE RANDOMIZED PHASE 2 STUDY, EVALUATING THE EFFICACY OF 5-FU + NALIRI AND 5-FU + NALIRINOX FOR METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (PDAC), PROGRESSIVE AFTER GEMCITABINE-ABRAXANE OR GEMCITABINE MONOTHERAPY.
RecruitingCTIS2024-516336-97-00
Start: 2022-02-21Target: 134Updated: 2025-02-25